TY - JOUR
T1 - Human parvoviruses may affect the development and clinical course of meningitis and meningoencephalitis
AU - Vilmane, Anda
AU - Terentjeva, Anna
AU - Tamosiunas, Paulius L.
AU - Suna, Normunds
AU - Suna, Inga
AU - Petraityte‐Burneikiene, Rasa
AU - Murovska, Modra
AU - Rasa‐Dzelzkaleja, Santa
AU - Nora‐ Krukle, Zaiga
N1 - Funding Information:
Funding: This study was supported by the cooperation project of the Taiwan‐Latvia‐Lithuania Mutual Funds «Studying of human parvovirus B19, bocavirus, and parvovirus 4 involvement in inflammatory neurological diseases using interdisciplinary approach» (a grant No. LV‐LT‐TW/2016/13//NR.6.2.‐26/2016/0073 and TAP LLT‐ 17‐012 funded by the State Education Development Agency Republic of Latvia and Research Council of Lithuania, respectively) and by the Latvian Council of Science grant No. 478/2012 «Elucidation of the involvement of β‐herpesviruses HHV‐6 and HHV‐7 infection in the development of encephalopathy, encephalitis, and epilepsy by using multidisciplinary approach».
Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/6
Y1 - 2020/6
N2 - Meningitis and meningoencephalitis are neurological inflammatory diseases, and although routine diagnostics include testing of a wide range of pathogens, still in many cases, no causative agent is detected. Human parvovirus B19 (B19V), human bocaviruses 1–4 (HBoV1–4), and human parvovirus 4 (hPARV4) are members of the Parvoviridae family and are associated with a wide range of clinical manifestations including neurological disorders. The main aim of this study was to determine whether human parvoviruses infection markers are present among patients with meningitis/meningoencephalitis in Latvia as well as to clarify the role of these viruses on the clinical course of the mentioned diseases. Our study revealed HBoV1–4 and B19V genomic sequences in 52.38% and 16.67% of patients, respectively. Furthermore, symptoms such as the presence of a headache and its severity, fatigue, disorientation, and difficulties to concentrate were significantly frequently present in patients with active parvovirus infection in comparison with parvoviruses negative patients, therefore we suggest that HBoV1–4 and B19V infection should be included in the diagnostics to reduce the number of meningitis/meningoencephalitis with unknown/unexplained etiology.
AB - Meningitis and meningoencephalitis are neurological inflammatory diseases, and although routine diagnostics include testing of a wide range of pathogens, still in many cases, no causative agent is detected. Human parvovirus B19 (B19V), human bocaviruses 1–4 (HBoV1–4), and human parvovirus 4 (hPARV4) are members of the Parvoviridae family and are associated with a wide range of clinical manifestations including neurological disorders. The main aim of this study was to determine whether human parvoviruses infection markers are present among patients with meningitis/meningoencephalitis in Latvia as well as to clarify the role of these viruses on the clinical course of the mentioned diseases. Our study revealed HBoV1–4 and B19V genomic sequences in 52.38% and 16.67% of patients, respectively. Furthermore, symptoms such as the presence of a headache and its severity, fatigue, disorientation, and difficulties to concentrate were significantly frequently present in patients with active parvovirus infection in comparison with parvoviruses negative patients, therefore we suggest that HBoV1–4 and B19V infection should be included in the diagnostics to reduce the number of meningitis/meningoencephalitis with unknown/unexplained etiology.
KW - Human bocaviruses 1-4
KW - Human parvovirus 4
KW - Human parvovirus B19
KW - Meningitis
KW - Meningoencephalitis
UR - http://www.scopus.com/inward/record.url?scp=85086046509&partnerID=8YFLogxK
U2 - 10.3390/brainsci10060339
DO - 10.3390/brainsci10060339
M3 - Article
AN - SCOPUS:85086046509
VL - 10
JO - Brain Sciences
JF - Brain Sciences
IS - 6
M1 - 339
ER -